Interim Results for six months ended 31 Dec 2024 | 31-Mar-2025 | 07:00 | RNS |
Advancement to final phase of PROTECT trial | 27-Mar-2025 | 07:00 | RNS |
New Executive Long Term Incentive Awards | 03-Mar-2025 | 07:00 | RNS |
Grass MATA MPL Phase III data published in Allergy | 17-Feb-2025 | 07:00 | RNS |
Grant of Options | 14-Feb-2025 | 07:00 | RNS |
Half Year Trading update | 28-Jan-2025 | 07:00 | RNS |
PDMR Dealing and Total Voting Rights | 22-Jan-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 15-Jan-2025 | 07:00 | RNS |
Exercise of Options and Total Voting Rights | 19-Dec-2024 | 13:41 | RNS |
Block Listing Interim Review | 17-Dec-2024 | 16:19 | RNS |
Result of Annual General Meeting | 16-Dec-2024 | 15:33 | RNS |
Positive Interim Data from PROTECT Trial | 04-Dec-2024 | 07:00 | RNS |
First Patient Dosed in G308 Paediatric Trial | 27-Nov-2024 | 07:00 | RNS |
Submission of MAA for Grass MATA MPL | 25-Nov-2024 | 07:00 | RNS |
Notice of 2024 Annual General Meeting | 21-Nov-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 7.45p |
Change Today | -0.050p |
% Change | -0.67 % |
52 Week High | 7.70 |
52 Week Low | 3.65 |
Volume | 387,795 |
Shares Issued | 4,766.44m |
Market Cap | £355.10m |
RiskGrade | 268 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 50,000 @ 7.10p |
16:35 | 1,000 @ 7.50p |
16:35 | 317 @ 7.50p |
16:35 | 50,000 @ 7.45p |
16:35 | 1,000 @ 7.45p |
You are here: research